Table 2.
Characteristics | n | CCDC19 (%) | P value | |
---|---|---|---|---|
| ||||
High expression | Low expression | |||
Gender | 0.022* | |||
Male | 99 | 42 | 57 | |
Female | 37 | 24 | 13 | |
Age (y) | 0.607 | |||
≥60 | 70 | 34 | 32 | |
<60 | 66 | 32 | 38 | |
Differentiated degree | 0.067 | |||
High | 22 | 15 | 7 | |
Middle | 36 | 19 | 17 | |
Low or undifferentiated | 78 | 32 | 46 | |
T classification | 0.479 | |||
T1+T2 | 115 | 54 | 61 | |
T3+T4 | 21 | 12 | 9 | |
N classification | 0.024* | |||
N0+N1 | 79 | 48 | 31 | |
N2+N3 | 57 | 23 | 34 | |
Distant metastasis | 0.496 | |||
Negative | 134 | 66 | 68 | |
Positive | 2 | 0 | 2 | |
Clinical stage | 0.124 | |||
I~II | 75 | 41 | 34 | |
III~IV | 61 | 25 | 36 |
Statistically significant.